March 11, 2026

The Timmerman Traverse has become a phenomenon in the biotech industry.  Numbers tell part of the story. More than 200 biotech industry leaders have participated since 2019. More than $15 million has been raised to support high-risk/high-reward cancer research, poverty alleviation, and newborn screening for sickle cell disease. Nonprofit organizations have seen awareness of their work, and their donor networks,... Read More